Dr. Frank Engler is a Clinical Pharmacologist with both preclinical and clinical drug development experience. Dr. Engler obtained his PhD from the University at Buffalo under the guidance of Dr. Joe Balthasar, followed by working in the pharmaceutical industry as a Clinical Pharmacologist. In addition to constructing clinical pharmacology development plans and designing studies, he has authored study reports, Investigator’s Brochures, protocols, SOPs, and INDs. His area of expertise includes pharmacokinetics (PK) and pharmacodynamics (PD), population-based and physiologically-based PK/PD modeling and simulation. Dr. Engler’s work has focused mainly in oncology, where he has experience with multiple therapeutic drug platforms, including monoclonal antibodies, antibody-drug conjugates, and small molecules.
Clinical Pharmacologist, Consulting Services
Home Office – Americas